Play Video: (Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
Description: At least 20% of PCI patients are High Bleeding Risk (HBR) where there is a need to avoid prolonged dual antipla-telet therapy (DAPT).1-9 BioFreedom, as a Drug-Coated Stent (DCS), is safer and more efficacious than BMS in High Bleeding Risk patients. nBy directly delivering BA9- an effective anti-restenotic therapy - without polymer or carrier and becoming a BMS at 28 days, the DAPT regime can be shortened when treating patients with the BioFreedom stent.
Play Video: (Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)